Determinants of Prostate-Specific Antigen Test Use in Prostate Cancer Screening by Primary Care Physicians

Archives of Family Medicine

Volumn 6, Issue 5, 1997, Pages 453-458

  Austin, Orson J ^a   Valente, Suzanne ^a   Hasse, Lora A ^a   Kues, John R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BLOOD; CLINICAL PRACTICE; FEMALE; HUMAN; IMMUNOLOGY; MALE; MASS SCREENING; MIDDLE AGED; PRIMARY HEALTH CARE; PROSTATE TUMOR; REGRESSION ANALYSIS; UNITED STATES; UTILIZATION REVIEW;

ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OHIO; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 0031226101     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.6.5.453     Document Type: Article

References (17)

1. Report of the US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996:119-134.
2. Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK. Prostate cancer screening: what we know and what we need to know. Ann Intern Med. 1993; 119:914-923.
3. Woolf SH. Screening for prostate cancer with prostate-specific antigen: an examination of the evidence. N Engl J Med. 1995;21:1401-1405.
4. US Dept of Health and Human Services. Clinician's Handbook of Preventive Services: Put Prevention Into Practice. Washington, DC: US Dept of Health and Human Services; 1994;205-207.
5. Williams RB, Boles M, Johnson RE. Use of prostate-specific antigen for prostate cancer screening in primary care practice. Arch Fam Med. 1995;4:311-315.
6. Hicks RJ, Hamm RM, Bemben DA. Prostate cancer screening: what family physicians believe is best. Arch Fam Med. 1995;4:317-322.
7. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;46:5-27.
8. Roetzheim RG, Herold AH. Prostate cancer screening. Prim Care. 1992;19:637-648.
9. Gerber GS, Chodak GW. Routine screening for cancer of the prostate. J Natl Cancer Inst. 1991;83:329-335.
10. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer: a decision analytic view. JAMA. 1994;272:773-780.
11. Wenneberg J. Prostate Disease: Patient Outcomes Research Team Final Report. Hanover, NH: Agency for Health Care Policy and Research; 1995:3-59. Publication PB95-253811.
12. Wolf AMD, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996; 156:1333-1336.
13. Adami HO, Baron JA, Rothman KJ. Ethics of a prostate cancer screening trial. Lancet. 1994;343:958-960.
14. Austin O, Ricer RE. Prostate cancer screening: an appraisal of the PSA test. Fam Pract Recertification. 1996;18:81-91.
15. Costanza ME, Stoddard AM, Zapka JG, Gaw VP, Barth R. Physician compliance with mammography guidelines: barriers and enhancers. J Am Board Fam Pract. 1992;5:143-152.
16. Fox SA, Klos DS, Tsou CV. Underuse of screening mammography by family physicians. Radiology. 1988;166:431-433.
17. Weinberger M, Saunders AF, Samsa GP, et al. Breast cancer screening in older women: practices and barriers reported by primary care physicians. J Am Geriatr Soc. 1991;39:22-29.